The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Bain Capital and Bristol Myers Squibb have formed a new biopharmaceutical company focused on developing new therapies for autoimmune diseases. The newly formed company launches with a $300 million ...

Bristol Myers Squibb and Bain Capital launch a new biopharma firm focused on autoimmune disease treatments, starting with 5 ...

Large private investment firm, Bain Capital, plans to sell its majority stake in an insurance broker and agency network based ...

Anne Hoecker, Bain & Company's head of global technology practice, joins CNBC's 'Squawk on the Street' to discuss the growth ...

Three decades of experience doing consumer research and observation for corporate clients led the authors—all with Bain & Company—to identify 30 “elements of value.” ...

News Bain Capital Specialty Finance Inc. Significant News Only 12 hours ago Press Release Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the Second Quarter Ended June 30, 2025 ...